Search
Subscribe Now
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Coins2Day 500
Coins2Day 500
Coins2Day 500 U.S.
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Drugs
Drugs
Page 28 of 29
Finance
Valeant comes out a winner after upping its Salix bid to $11.1 billion
By
Laura Lorenzetti
March 16, 2015
Features
FDA approves the first biosimilar for the U.S. market
By
Laura Lorenzetti
March 6, 2015
Finance
AbbVie to buy cancer drug maker Pharmacyclics in $21 billion deal
By
Reuters
March 5, 2015
Retail
Rite Aid takes aim at CVS with a $2 billion purchase
By
Laura Lorenzetti
February 11, 2015
Features
Biosimilars may one day save your life. But what are they?
By
Laura Lorenzetti
February 6, 2015
Finance
After Allergan loss, is Valeant dumpster diving?
By
Jen Wieczner
January 31, 2015
How to stop generic drug shortages: end hospital group purchasing kickbacks
By
Phillip L. Zweig
and
Robert A. Campbell
January 30, 2015
Report predicts 18 states will legalize pot by 2020
By
TIME
January 26, 2015
Features
Regeneron vaults ahead of Amgen in race to market cholesterol drug
By
Reuters
January 26, 2015
Retail
High stakes: How this marijuana company gained buzz in a budding market
By
Entrepreneur
and
Ben Geier
December 26, 2014
Leadership
The war on drugs comes to Corporate America
By
Chris Matthews
December 2, 2014
Japan’s Otsuka to buy U.S. drug maker Avanir for $3.5 billion
By
Laura Lorenzetti
December 2, 2014
International
Merck buys the rights to an experimental Ebola vaccine
By
Reuters
November 24, 2014
Features
5 things that will kill you before Ebola does
By
Verne Kopytoff
October 30, 2014
International
Hands off our hookers’ and dope dealers’ money, U.K. tells E.U.
By
Geoffrey Smith
October 24, 2014
Most Popular
Economy
'I just don't have a good feeling about this': Top economist Claudia Sahm says the economy quietly shifted and...
By
Eleanor Pringle
Future of Work
Ford CEO has 5,000 open mechanic jobs with up to 6-figure salaries from the shortage of manually skilled workers: 'We...
By
Marco Quiroz-Gutierrez
Big Tech
The Chan Zuckerberg Initiative cut 70 jobs as the Meta CEO’s philanthropy goes all in on mission to 'cure or prevent...
By
Sydney Lake